Clinical Trial

"Triple Negative" Adult B-cell Acute Lymphoblastic Leukemia - TRINEG-ALL

Study acronym: TRINEG-ALL
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 9, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
It is a multicenter, non-interventional, non pharmacological, translational, prospective study. Any decision about drug administration is made by the physician based on his clinical judgment in the context of clinical practice, independently from the decision to include the patient in the study.
Trial Details
NCT Number NCT06919393
Lead Sponsor Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Conditions Leukemia, Lymphoblastic
Enrollment 60 participants
Start Date 2019-10-23
Primary Completion 2026-01 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-09